Alector raises $29.5 mln
Alector LLC said Thursday that raised $29.5 million in a Series D financing led by the Dementia Discovery Fund, with new investors Amgen Ventures and AbbVie joining the syndicate. Existing investors Merck Research Lab Ventures, OrbiMed, Polaris Partners, GV (formerly Google Ventures), Topspin Partners and Mission Bay Capital participated in the financing. Alector, a biotechnology company, is developing immuno-modulatory therapies for Alzheimer’s disease and other neurodegenerative disorders.
7 January 2016•3 mins read
